We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+1.71%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$3.82B
AUM Growth
-$203M
Cap. Flow
-$147M
Cap. Flow %
-3.86%
Top 10 Hldgs %
10.9%
Holding
1,910
New
566
Increased
402
Reduced
324
Closed
599

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$59.4M
2
V icon
Visa
V
+$52.1M
3
MDLZ icon
Mondelez International
MDLZ
+$49.1M
4
ORCL icon
Oracle
ORCL
+$38.4M
5
CSCO icon
Cisco
CSCO
+$35.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.13%
2 Healthcare 14.06%
3 Technology 13.88%
4 Industrials 11.8%
5 Financials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
226
Agilent Technologies
A
$39.1B
$4.39M 0.11%
113,794
-29,541
-21% -$1.23M
OSPN icon
227
OneSpan
OSPN
$562M
$4.38M 0.11%
+145,197
New +$3.95M
PVH icon
228
PVH
PVH
$3.71B
$4.36M 0.11%
+37,860
New +$4.11M
JACK icon
229
Jack in the Box
JACK
$278M
$4.27M 0.11%
+48,460
New +$4.35M
MIDD icon
230
Middleby
MIDD
$6.05B
$4.24M 0.11%
37,773
+23,773
+170% +$2.54M
TSN icon
231
Tyson Foods
TSN
$20.2B
$4.23M 0.11%
99,300
-600
-0.6% -$24.6K
AJG icon
232
Arthur J. Gallagher & Co
AJG
$63.7B
$4.22M 0.11%
89,310
-19,608
-18% -$944K
ELLI
233
DELISTED
Ellie Mae Inc
ELLI
$4.22M 0.11%
+60,418
New +$3.76M
HZNP
234
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.17M 0.11%
120,187
+21,857
+22% +$667K
RRC icon
235
Range Resources
RRC
$9.11B
$4.14M 0.11%
83,807
-26,996
-24% -$1.54M
ESS icon
236
Essex Property Trust
ESS
$18.9B
$4.12M 0.11%
19,392
+17,019
+717% +$3.77M
ALV icon
237
Autoliv
ALV
$8.6B
$4.09M 0.11%
+48,677
New +$4.28M
NHTC icon
238
Natural Health Trends
NHTC
$15.4M
$4.09M 0.11%
+98,641
New +$2.92M
INTU icon
239
Intuit
INTU
$81.1B
$4M 0.1%
39,710
+16,898
+74% +$1.72M
KKD
240
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$3.99M 0.1%
207,127
+195,008
+1,609% +$3.62M
TEVA icon
241
Teva Pharmaceuticals
TEVA
$35.9B
$3.98M 0.1%
+67,409
New +$4.16M
IDTI
242
DELISTED
Integrated Device Technology I
IDTI
$3.97M 0.1%
183,148
+125,111
+216% +$2.7M
XL
243
DELISTED
XL Group Ltd.
XL
$3.95M 0.1%
+106,126
New +$3.98M
ADM icon
244
Archer Daniels Midland
ADM
$41.4B
$3.94M 0.1%
+81,792
New +$4.13M
BNCL
245
DELISTED
Beneficial Bancorp, Inc.
BNCL
$3.93M 0.1%
314,926
+177,755
+130% +$2.13M
DBRG icon
246
DigitalBridge
DBRG
$2.94B
$3.93M 0.1%
53,160
+41,093
+341% +$3.49M
SYNH
247
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$3.93M 0.1%
97,970
+85,654
+695% +$2.96M
PLAY icon
248
Dave & Buster's
PLAY
$343M
$3.92M 0.1%
108,500
+67,691
+166% +$2.27M
MO icon
249
Altria Group
MO
$122B
$3.9M 0.1%
79,759
-691,986
-90% -$35.1M
DHC
250
Diversified Healthcare Trust
DHC
$2.26B
$3.9M 0.1%
+223,987
New +$4.44M

Similar funds

PDT Partners's Q2 2015 Portfolio in Review

As of Q2 2015, PDT Partners held 1,910 positions worth $3.82B, down 5% from $4.03B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

PDT Partners withdrew a net $147M in Q2 2015, closing 599 positions and reducing 324 holdings. Its most notable exit was General Motors, an estimated $59.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, PDT Partners opened a new position in Coca-Cola worth $50.9M.

  • PDT Partners's largest Q2 2015 buy was Coca-Cola: 1,297,098 shares worth $50.9M.
  • PDT Partners added most to Ambarella in Q2 2015, an estimated $40.4M increase.
  • PDT Partners's biggest Q2 2015 reduction was Visa, cutting an estimated $52.1M.
  • PDT Partners fully exited General Motors in Q2 2015, selling an estimated $59.4M.
  • PDT Partners's ten largest holdings make up 11% of its $3.82B portfolio in Q2 2015.
  • PDT Partners opened 566 new positions and closed 599 in Q2 2015.
  • PDT Partners's portfolio value fell 5% quarter-over-quarter to $3.82B.

Based on PDT Partners's 13F filing for Q2 2015, filed 14 Aug 2015.